Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Neuromuscul Dis ; 22(3): 173-179, 2021 Mar 01.
Article in English | MEDLINE | ID: mdl-33596003

ABSTRACT

ABSTRACT: Collagen VI-related myopathies are caused by mutations of COL6A1, COL6A2, and COL6A3 and present with a wide phenotypic spectrum ranging from severe Ulrich congenital muscular dystrophy to mild Bethlem myopathy. Here, we report a consanguineous Kurdish family with 3 siblings affected by autosomal-recessive Bethlem myopathy caused by compound heterozygous mutations of COL6A3. We found the previously described missense mutation c.7447A > G/p.(Lys2483Glu) and a novel large deletion encompassing the exon 1-39 of the COL6A3 gene. Apart from the classical clinical symptoms, all patients had keratoconus, which expands the phenotype of the collagen VI-related myopathies.


Subject(s)
Collagen Type VI/genetics , Muscular Diseases/genetics , Mutation/genetics , Adult , Child , Child, Preschool , Contracture/genetics , Exons , Female , Humans , Male , Muscle, Skeletal , Muscular Dystrophies/congenital , Muscular Dystrophies/genetics , Mutation, Missense , Phenotype , Young Adult
4.
Neurology ; 90(5): e412-e418, 2018 01 30.
Article in English | MEDLINE | ID: mdl-29298851

ABSTRACT

OBJECTIVE: To characterize the phenotype of patients with symptoms of periodic paralysis (PP) and ryanodine receptor (RYR1) gene mutations. METHODS: Cases with a possible diagnosis of PP but additional clinicopathologic findings previously associated with RYR1-related disorders were referred for a tertiary neuromuscular clinical assessment in which they underwent detailed clinical evaluation, including neurophysiologic assessment, muscle biopsy, and muscle MRI. Genetic analysis with next-generation sequencing and/or targeted Sanger sequencing was performed. RESULTS: Three cases with episodic muscle paralysis or weakness and additional findings compatible with a RYR1-related myopathy were identified. The McManis test, used in the diagnosis of PP, was positive in 2 of 3 cases. Genetic analysis of known PP genes was negative. RYR1 analysis confirmed likely pathogenic variants in all 3 cases. CONCLUSIONS: RYR1 mutations can cause late-onset atypical PP both with and without associated myopathy. Myalgia and cramps are prominent features. The McManis test may be a useful diagnostic tool to indicate RYR1-associated PP. We propose that clinicopathologic features suggestive of RYR1-related disorders should be sought in genetically undefined PP cases and that RYR1 gene testing be considered in those in whom mutations in SCN4A, CACNA1S, and KCNJ2 have already been excluded.


Subject(s)
Mutation/genetics , Myalgia/genetics , Paralyses, Familial Periodic/genetics , Ryanodine Receptor Calcium Release Channel/genetics , Electromyography , Evoked Potentials, Motor/physiology , Female , Humans , Magnetic Resonance Imaging , Male , Middle Aged , Muscle, Skeletal/diagnostic imaging , Muscle, Skeletal/physiopathology , Myalgia/diagnostic imaging , Myalgia/physiopathology , Paralyses, Familial Periodic/diagnostic imaging , Paralyses, Familial Periodic/physiopathology , Phenotype
6.
Genet Med ; 8(11): 728-34, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17108765

ABSTRACT

PURPOSE: Current diagnostic methods for chromosomal abnormalities rely mainly on karyotyping and occasionally fluorescent in situ hybridization or quantitative polymerase chain reaction. We describe an alternative molecular method for the detection of trisomy 21 involving mass spectrometric analysis of single nucleotide polymorphisms. METHODS: In collaboration with Sequenom, Inc., 350 blinded amniotic fluid, amniocyte culture, chorionic villus, or amniotic fluid supernatant samples were analyzed for trisomy 21 using SNP analysis and matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Peak ratios were calculated for heterozygous genotypes and compared to control values generated from known euploid samples. An analytical algorithm using standard deviations from control values was used to determine the probability of a sample being affected or unaffected. RESULTS: Seventy-three trisomy 21 samples from among the 350 blinded samples were correctly identified. There were no false-positive or false-negative results among the complete trisomy 21 samples. One sample exhibiting mosaicism for trisomy 21 was identified as being unaffected. CONCLUSIONS: MALDI-TOF mass spectrometry is a robust and reproducible method for the detection of trisomy 21. Its amenability to high-throughput analysis and high degree of multiplexing make it a potential future diagnostic tool for the detection of other aneuploidies as well.


Subject(s)
Down Syndrome/diagnosis , Prenatal Diagnosis/methods , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Algorithms , Amniotic Fluid/chemistry , Chromosomes, Human, Pair 21 , Female , Gene Frequency , Humans , Polymorphism, Single Nucleotide , Pregnancy , Reproducibility of Results
7.
Retina ; 26(8): 947-53, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17031298

ABSTRACT

PURPOSE: To report a complex mutation in the peripherin/RDS gene found in a family in whom retinal pattern dystrophy is segregating as an autosomal dominant trait. METHODS: Clinical data were collected from family members of a large Swiss family affected by autosomal dominant retinal pattern dystrophy. Single strand conformation polymorphism (SSCP) analysis of the candidate gene peripherin/RDS and subsequent sequencing of the first exon were performed. RESULTS: Pattern dystrophy of the retina was suspected in 18 family members aged 30 years or older. Assuming a homogeneous phenotype, the candidate locus peripherin/RDS was investigated. SSCP analysis of the first exon of the peripherin/RDS gene showed an aberrant pattern in 18 affected individuals. Direct sequencing of polymerase chain reaction products detected a complex mutation, del265-268GCCA ins AGGGCC, leading to a stop codon at amino acid position 99. CONCLUSION: To our knowledge, we report the first complex mutation in the peripherin/RDS gene as the cause of a mild macular phenotype, supporting the importance of molecular diagnosis in genetic counseling.


Subject(s)
Intermediate Filament Proteins/genetics , Membrane Glycoproteins/genetics , Mutation , Nerve Tissue Proteins/genetics , Retinal Degeneration/genetics , Adult , Aged , DNA Mutational Analysis , Exons/genetics , Female , Fluorescein Angiography , Genes, Dominant , Humans , Male , Middle Aged , Pedigree , Peripherins , Polymerase Chain Reaction , Polymorphism, Single-Stranded Conformational
8.
Hum Mutat ; 27(6): 558-67, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16673358

ABSTRACT

The International Registry of Werner syndrome (www.wernersyndrome.org) has been providing molecular diagnosis of the Werner syndrome (WS) for the past decade. The present communication summarizes, from among 99 WS subjects, the spectrum of 50 distinct mutations discovered by our group and by others since the WRN gene (also called RECQL2 or REQ3) was first cloned in 1996; 25 of these have not previously been published. All WRN mutations reported thus far have resulted in the elimination of the nuclear localization signal at the C-terminus of the protein, precluding functional interactions in the nucleus; thus, all could be classified as null mutations. We now report two new mutations in the N-terminus that result in instability of the WRN protein. Clinical data confirm that the most penetrant phenotype is bilateral ocular cataracts. Other cardinal signs were seen in more than 95% of the cases. The median age of death, previously reported to be in the range of 46-48 years, is 54 years. Lymphoblastoid cell lines (LCLs) have been cryopreserved from the majority of our index cases, including material from nuclear pedigrees. These, as well as inducible and complemented hTERT (catalytic subunit of human telomerase) immortalized skin fibroblast cell lines are available to qualified investigators.


Subject(s)
DNA Helicases/genetics , Werner Syndrome/diagnosis , Werner Syndrome/genetics , Adult , Aged , Aged, 80 and over , Amino Acid Sequence , DNA Helicases/chemistry , DNA Mutational Analysis , Exodeoxyribonucleases , Humans , Middle Aged , Models, Molecular , Molecular Sequence Data , Pedigree , RecQ Helicases , Registries , Sequence Alignment , Werner Syndrome/mortality , Werner Syndrome Helicase
SELECTION OF CITATIONS
SEARCH DETAIL
...